NEW YORK (GenomeWeb News) – Beckman Coulter today reported a double-digit increase in revenues for the three months ended Dec. 31, while soaring R&D costs, affected by a charge related to the acquisition of NexGen Diagnostics, cut the firm’s profit 28 percent year over year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.